EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

Value in Health, Volume 17, Issue 4, Pages 471-475, June 2014
Authors:C. Daniel Mullins, PhD; Joseph Vandigo, MBA; Zhiyuan Zheng, PhD; Paul Wicks, PhD

To view the article, please click here.







Recent news

» Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languages

» The FDA approves the first anti-BCMA CAR-T Cell Therapy for myeloma, idecabtagene vicleucel (Abecma)

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.